Therefore, due to the central role of TGF-β in the immunosuppressive tumor microenvironment (Tauriello et al., 2022), blockade of TGF-β signaling pathway to remodel the tumor microenvironment would be a promising strategy to enhance chemoimmunotherapy efficiency. Here, TGFB1 is linked to neoplasm.